E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/22/2006 in the Prospect News Biotech Daily.

Cepheid GeneXpert system receives Homeland Security certification

By Lisa Kerner

Erie, Pa., March 22 - Cepheid said it has received both certification and designation of the GeneXpert technology as qualified anti-terrorism technology.

GeneXpert is now listed among products approved by the Department of Homeland Security and is granted coverage under the Support Anti-Terrorism by Fostering Effective Technology (Safety) Act, which encourages the development and deployment of anti-terrorism technologies that will enhance the protection of the nation, according to a company news release.

"All Cepheid suppliers, vendors and customers benefit from the protection of Safety Act certification knowing that the GeneXpert system meets the government's most stringent standards for biothreat technology," chief executive officer John Bishop said in the release.

"The GeneXpert technology has been demonstrated to be an accurate and effective solution to meeting varying needs in the potential detection of biothreat agents."

Cepheid's GeneXpert combines sample preparation with real-time polymerase chain reaction amplification and detection for fully integrated and automated DNA analysis.

The system purifies, concentrates, detects and identifies targeted nucleic acid sequences, delivering results in minutes, the company said. No specialized facilities or highly skilled laboratory training is required to operate the GeneXpert system.

Cepheid, based in Sunnyvale, Calif., is a molecular diagnostics company that develops, manufactures and markets systems for genetic analysis in the clinical, industrial and biothreat markets.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.